Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases

Affiliations

¹ Department of Medicine, Rheumatology Unit, Universita degli Studi di Verona, Verona, Italy alessandrogiollo@gmail.com.
² Department of Medicine, Rheumatology Unit, Universita degli Studi di Verona, Verona, Italy.
³ Department of Radiology, University of Verona, Verona, Veneto, Italy.

Comment

Alessandro Giollo et al. Ann Rheum Dis. 2022 Nov.

. 2022 Nov;81(11):e222.

doi: 10.1136/annrheumdis-2020-218845. Epub 2020 Sep 7.

¹ Department of Medicine, Rheumatology Unit, Universita degli Studi di Verona, Verona, Italy alessandrogiollo@gmail.com.
² Department of Medicine, Rheumatology Unit, Universita degli Studi di Verona, Verona, Italy.
³ Department of Radiology, University of Verona, Verona, Veneto, Italy.

No abstract available

Keywords: antirheumatic agents; arthritis; biological Therapy; glucocorticoids; inflammation; rheumatoid.

Conflict of interest statement

Competing interests: None declared.

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance. Gianfrancesco M, et al. Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29. Ann Rheum Dis. 2020. PMID: 32471903 Free PMC article.